Side Effects of Atropine (SEA) Study

Completed · Phase 1/Phase 2

Conditions studied: Myopia

In brief

This study will perform several objective and subjective measurements of the eye and vision before and after a week of using 0.01% concentration atropine drops. These measurements will help to obtain a comprehensive understanding of the side effects of this concentration of atropine and determine if the drops would be tolerated as a possible preventative treatment for nearsightedness.

Key facts

Study ID

NCT03593044

Run by

Jeffrey J. Walline, OD PhD

People needed

31

Starts

2018-07-23

Expected to finish

2019-01-17

Last updated by the study team

2022-12-02

Who can join

Age: 21 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• N/A

You may not qualify if…

• Outside of age range
• History of accommodative (focusing) issues or therapy

Where it is running

• Ohio State University College of Optometry — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.